Bethesda, Md. — Richard Kaufman, MD, has been appointed to be the next Editor-in-Chief of Transfusion, AABB’s scholarly, peer-reviewed monthly journal. Kaufman will begin serving in this role in April 2018.
Transfusion is widely considered to be the world’s foremost journal for transfusion medicine research. The journal regularly publishes original research articles, discussions with opposing viewpoints on controversial issues, and key conference proceedings. In addition to blood banking and transfusion medicine, Transfusion is a leading source for research and information on cellular therapies, patient blood management and tissue transplantation.
The Editor-in-Chief of Transfusion provides direction for the journal by setting policy, planning strategy, promoting contributions and determining overall content. Kaufman will take over the Editor-in-Chief position from Paul Ness, MD, who elected to end his term of service after holding the position since 2003.
Kaufman has served as an Associate Editor of Transfusion since 2013. In addition, he was most recently a member of the AABB Board of Directors and has been an active member of AABB since 2000. As a member of AABB’s Clinical Transfusion Medicine Committee, Kaufman led the development of AABB’s platelet transfusion guidelines.
In addition to his work with AABB, Kaufman is the medical director of the blood bank and transfusion service at the Brigham and Women’s Hospital in Boston and an associate professor of pathology at Harvard Medical School. He received his Bachelor of Science degree in zoology from Duke University in Durham, N.C. and his medical degree from Washington University School of Medicine in St. Louis, Mo. He completed both his clinical pathology residency and transfusion medicine fellowship training at Barnes-Jewish Hospital and Washington University School of Medicine. He is board-certified in clinical pathology and has subspecialty certification in blood banking and transfusion medicine.
“Dr. Kaufman is an ideal candidate to serve as the next Editor-in-Chief of Transfusion,” said Ness. “With his strong background in blood banking and transfusion medicine, Dr. Kaufman possesses valuable expertise in the field and a broad understanding of the future direction of research. Transfusion will be well-served by Dr. Kaufman’s widespread knowledge, vast experience and passionate interest in the subject matter.”
Kaufman will be assuming his new role as Transfusion’s prominence is increasing. The journal’s editors recently announced that in the most recent impact factor report, Transfusion's 2016 impact factor increased to 3.386, up from 3.042 in the previous year.
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.